Long non-coding RNA KCNQ1OT1 facilitates the progression of cervical cancer and tumor growth through modulating miR-296-5p/HYOU1 axis

References

• Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015;15(7):805–810.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Tian T, Gao X, Ju Y, et al. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma. Arch Gynecol Obstet. 2020;303(3):793–801.
   Web of Science ®Google Scholar
• Kim H, Cho WK, Kim YJ, et al. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy. Gynecol Oncol. 2020;157(2):423–428.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang Z, Yang N, et al. Identification of biomarkers for cervical cancer radiotherapy resistance based on RNA sequencing data. Front Cell Dev Biol. 2021;9:724172.
   PubMed Web of Science ®Google Scholar
• Yamanaka Z, Sasaki T, Yamanaka A, et al. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. Cancer Biomark. 2021. DOI:10.3233/CBM-201021
   PubMed Web of Science ®Google Scholar
• Galvão M, Coimbra EC. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects. Crit Rev Oncol Hematol. 2020;156:103111.
   PubMed Web of Science ®Google Scholar
• He J, Huang B, Zhang K, et al. Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity. Biomed Pharmacother. 2020;127:110209.
   PubMed Web of Science ®Google Scholar
• Cheng JL, Li DJ, Lv MY, et al. LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149. Cancer Gene Ther. 2020;28(7–8):850–863.
   Web of Science ®Google Scholar
• Wang Y, Zhang L, Yang J, et al. LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer. Cancer Cell Int. 2020;20(1):144.
   PubMed Web of Science ®Google Scholar
• Lei HW, Gao Y, Shi JB, et al. KCNQ1 opposite strand/antisense transcript 1 promotes aggressive biological behaviors of cervical cancer cells via regulating microRNA-491-5p and pyruvate kinase M1/2. J Biol Regul Homeost Agents. 2020;34:5.
   PubMedGoogle Scholar
• Li S, Yang S, Qiu C, et al. LncRNA MSC-AS1 facilitates lung adenocarcinoma through sponging miR-33b-5p to up-regulate GPAM. Biochem Cell Biol. 2021;99(2):241–248.
   PubMedGoogle Scholar
• Zhang X, Zheng W, Jiang W, et al. Long non-coding RNA SNHG3 accelerates progression in glioma by modulating miR-384/HDGF axis. Open Life Sci. 2020;15(1):654–664.
   PubMed Web of Science ®Google Scholar
• Arts FA, Keogh L, Smyth P, et al. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma. Hum Pathol. 2017;70:98–104.
   PubMed Web of Science ®Google Scholar
• Li MM, Liu XH, Zhao YC, et al. Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR-296-5p/Bax axis. FEBS J. 2020;287(3):561–577.
   PubMed Web of Science ®Google Scholar
• Ma WG, Shi SM, Chen L, et al. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway. J Cell Biochem. 2020;122(2):235–248.
   Web of Science ®Google Scholar
• Xie J, Chen Q, Zhou P, et al. Circular RNA hsa_circ_0000511 improves epithelial mesenchymal transition of cervical cancer by regulating hsa-mir-296-5p/HMGA1. J Immunol Res. 2021;2021:9964538.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang NX, Ye HY, et al. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis. Eur Rev Med Pharmacol Sci. 2019;23(10):4126–4135.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liao Q, Li X, et al. HYOU1, regulated by LPLUNC1, is up-regulated in nasopharyngeal carcinoma and associated with poor prognosis. J Cancer. 2016;7(4):367–376.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Hasanzadeh M, ShahidSales S, et al. Clinical significance and prognosis value of wnt signaling pathway in cervical cancer. J Cell Biochem. 2017;118(10):3028–3033.
   PubMed Web of Science ®Google Scholar
• Yang M, Wang M, Li X, et al. Wnt signaling in cervical cancer. J Cancer. 2018;9(7):1277–1286.
   PubMed Web of Science ®Google Scholar
• Luo ZP, Jin H. Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 2019;23(20):8788–8794.
   PubMed Web of Science ®Google Scholar
• Gao X, Ge J, Li W, et al. LncRNA KCNQ1OT1 promotes osteogenic differentiation to relieve osteolysis via Wnt/β-catenin activation. Cell Biosci. 2018;8(1):19.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Tomao F, Santangelo G, Musacchio L, et al. Targeting cervical cancer: Is there a role for poly (ADP-ribose) polymerase inhibition. J Cell Physiol. 2020;235(6):5050–5058.
   PubMed Web of Science ®Google Scholar
• Berumen J, Espinosa AM, Targeting MI. CDKN3 in cervical cancer. Expert Opin Ther Targets. 2014;18(10):1149–1162.
   PubMed Web of Science ®Google Scholar
• Duan Q, Cai L, Zheng K, et al. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway. Oncol Lett. 2020;20(1):601–610.
   PubMed Web of Science ®Google Scholar
• Li Y, Shi B, Dong F, et al. LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1. Cancer Gene Ther. 2020;28(3–4):212–220.
   Web of Science ®Google Scholar
• Tornesello ML, Faraonio R, Buonaguro L, et al. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 2020;10:150.
   PubMed Web of Science ®Google Scholar
• Lv L, Wang X. MicroRNA-296 targets specificity protein 1 to suppress cell proliferation and invasion in cervical cancer. Oncol Res. 2018;26(5):775–783.
   PubMed Web of Science ®Google Scholar
• Giffin L, Yan F, Ben Major M, et al. Modulation of Kaposi’s sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1. J Virol. 2014;88(16):9429–9441.
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Hooke JA, Shriver CD, et al. HYOU1/Orp150 expression in breast cancer. Med Sci Monit. 2007;13(11):BR231–239.
   PubMed Web of Science ®Google Scholar
• Shang S, Hua F, Hu ZW. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget. 2017;8(20):33972–33989.
   PubMedGoogle Scholar
• Tian W, Lei N, Guo R, et al. Long non-coding RNA DANCR promotes cervical cancer growth via activation of the Wnt/β-catenin signaling pathway. Cancer Cell Int. 2020;20(1):61.
   PubMed Web of Science ®Google Scholar
• Li Q, Yu X, Yang L. MiR-145 inhibits cervical cancer progression and metastasis by targeting WNT2B by Wnt/β-catenin pathway. Int J Clin Exp Pathol. 2019;12(10):3740–3751.
   PubMed Web of Science ®Google Scholar
• Sun WM, Tao W, Li JC, et al. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(23):10422–10432.
   PubMed Web of Science ®Google Scholar